If you would like to receive information when Fenzian treatment for asthma becomes available please register your details
Fenzian and asthma
Unexpected results whilst treating pain.
Patients who were receiving Fenzian treatment for pain who happened also to have asthma found that their asthma ceased. These unexpected findings prompted formal clinical studies, now being completed outside Europe, to test possible Fenzian use in asthma and if it is found to be valuable, Fenzian may seek regulatory approval for wider use in asthma to add to the FDA 510(k) for use in pain and biofeedback.
A statistically significant first asthma pilot study
A first asthma pilot study was conducted through UCLA in California in 2008. This small study amongst ‘mild to moderate’ asthmatics produced statistically significant results and excited considerable interest at the American Thoracic Society’s Annual Convention; the biggest respiratory event of the year. The results were also published in the internationally respected European Respiratory Journal (link).
UCLA asked to coordinate a larger study amongst mild to moderate asthmatics and organised a multi-centre trial amongst a total of six participating sites. Results for this study are still awaited.
Due to the delays in the multi-centre study under UCLA, a second pilot study was undertaken in severe asthma patients in Barbados, where asthma affects 10% of the population. This was conducted in conjunction with Johns Hopkins, and the highly encouraging outcomes were presented at the 2012 American Thoracic Society meeting in San Francisco. Further studies are being undertaken as result and should be complete by April 2014.
|(Asthma-inducing) pollution over Cape Town|
“I was told my hand would never recover. After Fenzian treatment I have completely recovered full use.”
Ulnar nerve palsy - Ken